Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics ...Middle East

PR Newswire - News
Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics
Company focused on continued advancement of its small molecule therapeutics platform including development of fezagepras and evaluating strategic alternatives for its plasma-derived therapeutics business and other non-core assets. LAVAL, Canada and CAMBRIDGE, England, Jan. 27, 2021...

Hence then, the article about liminal biosciences provides update on business strategy and focus on small molecule therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Liminal BioSciences Provides Update on Business Strategy and Focus on Small Molecule Therapeutics )

Apple Storegoogle play

Last updated :

Also on site :